Bipolar i disorder Trials in Orlando, United States
Conditions / Bipolar i disorder / Orlando, United States
Research into Bipolar i disorder spans multiple therapeutic approaches and trial phases.
11 total trials for this combination
Showing top 10 of 11 trials
Trials
| NCT ID | Title | Status | Phase |
|---|---|---|---|
| NCT01058668 | Safety and Efficacy of Cariprazine for Bipolar I Disorder | COMPLETED | PHASE3 |
| NCT04578756 | Open-Label, Flexible-dose Study to Evaluate the Long-Term Safety and Tolerability of Cariprazine in the Treatment of Pediatric Participants With Schizophrenia, Bipolar I Disorder, or Autism Spectrum Disorder | COMPLETED | PHASE3 |
| NCT04777357 | A Study to Assess Change in Disease Activity and Adverse Events (AEs) With Cariprazine in the Treatment of Depressive Episodes in Pediatric Participants Participants (10 to 17 Years of Age) With Bipolar I Disorder. | RECRUITING | PHASE3 |
| NCT00114686 | Efficacy and Safety of Quetiapine Fumarate (SEROQUEL®) in the Treatment of Alcohol Dependency in Patients With Bipolar Disorder | COMPLETED | PHASE3 |
| NCT06696755 | A Study to Assess Adverse Events and Change in Disease Activity of Oral Icalcaprant in Adult Participants With Bipolar I or II Disorder | RECRUITING | — |
| NCT07217860 | An Open-label Study of Azetukalner in Bipolar I or II Depression (X-CEED-OLE) | ENROLLING_BY_INVITATION | PHASE3 |
| NCT07172516 | A Randomized Study of Azetukalner Versus Placebo in Depressive Episodes Associated With Bipolar I or II Disorder (Bipolar Depression) | RECRUITING | PHASE3 |
| NCT01358357 | Bipolar Maintenance Study of Lurasidone Adjunctive to Lithium or Divalproex | COMPLETED | PHASE3 |
| NCT06696755 | A Study to Assess Adverse Events and Change in Disease Activity of Oral Icalcaprant in Adult Participants With Bipolar I or II Disorder | RECRUITING | — |
| NCT01575561 | This is an Open-label, Multi-center, Extension Study Designed to Evaluate the Longer Term Safety, Tolerability and Effectiveness of Lurasidone, Flexibly Dosed, Adjunctive to Lithium or Divalproex for the Treatment of Subjects With Bipolar I Disorder Who Have Participated in Study D1050296 | COMPLETED | PHASE3 |